Human Metabolome Technologies Signs Biomarker Deal with Mitsubishi Pharma

genomeweb
360dx

Human Metabolome Technologies Signs Biomarker Deal with Mitsubishi Pharma

Feb 17, 2005

NEW YORK, Feb. 17 (GenomeWeb News) - Human Metabolome Technologies of Yamagata, Japan, yesterday announced a biomarker research collaboration with Mitsubishi Pharma.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Epigenetic Variations Could Underlie Neurodevelopmental Disorders, Congenital Anomalies
Becton Dickinson Prices $685M Senior Notes Offering
New Method Traces Demographic History of Admixed Populations Using Genome Data
Functional Assays Improve Classification of Potential Cystic Fibrosis Risk Variants
Cancer Increase Reported in Families With Tau Mutation-Associated Neurodegeneration
Precipio Inks Distribution Deal With Italy's Euroclone Diagnostica

The Scan

Make Sense of It All

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

Variations on Results

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

This Week in Nature

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

Of Many Minds

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.

Main menu